Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited is a mainboard IPO raising ₹165 crores through a combination of fresh issue and offer for sale, offering fertility treatment services across 30+ locations in India under an asset-light hub-and-spoke model.
Overview
About the Company
Incorporated in March 2015, Gaudium IVF and Women Health Limited is a leading provider of assisted reproductive technology (ART) services in India. The company was founded by Dr. Manika Khanna and operates more than 30 locations across India through an asset-light hub-and-spoke model consisting of seven hubs and twenty-eight spokes. It offers a comprehensive range of fertility treatments including In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, catering to both male and female infertility. The company also provides specialised gynaecological care for conditions like PCOD/PCOS and endometriosis, as well as high-risk pregnancy management. Its hub centres are located in key cities such as Delhi (Janakpuri and Kailash Colony), Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore. It also serves patients from multiple countries including Canada, the UK, the USA, Kenya, South Africa, and Oman. The company was converted from a private limited to a public limited entity in October 2024 and is promoted by Dr. Manika Khanna, Dr. Peeyush Khanna, and Vishad Khanna.
Company Details
📋 Objects of Issue (Use of Proceeds)
- › Deployment of capital expenditure towards setting up new IVF centres across India to expand the company's network and treatment capacity.
- › Full or partial repayment and pre-payment of outstanding loans availed by the company to reduce its debt burden.
- › Utilisation of funds for general corporate purposes to support day-to-day operations and other business requirements.
✅ Strengths
- ✓ The company was established by Dr. Manika Khanna, a highly experienced IVF specialist whose clinical expertise and reputation underpin the brand's credibility.
- ✓ Gaudium IVF has built a widespread presence across India with over 30 locations, leveraging a scalable hub-and-spoke model that keeps capital requirements lean.
- ✓ The company offers a wide spectrum of fertility services including IVF, ICSI, and IUI, enabling it to address diverse patient needs under one roof.
- ✓ Revenue and profitability have demonstrated strong upward momentum in recent years, reflecting growing patient volumes and operational efficiency.
- ✓ India's IVF services market is experiencing rapid growth driven by rising infertility awareness, and the company is well-positioned to capture a significant share of this expanding opportunity.
- ✓ The company follows a patient-centric approach supported by a highly skilled expert clinical team.
- ✓ Gaudium IVF uses next-generation INTEGRA Ti labs for ICSI procedures and advanced USG-guided services, reflecting a commitment to cutting-edge clinical technology.
⚠️ Risks
- ! The company carries significant contingent liabilities in relation to its net worth, which could pose financial challenges if such liabilities materialise.
- ! As a healthcare provider, Gaudium IVF faces inherent operational and legal risks including patient safety concerns and potential malpractice liabilities.
- ! The business is heavily dependent on retaining skilled doctors and embryologists, and high attrition among such specialised staff could disrupt service quality.
- ! A large portion of the company's brand equity and leadership is tied to its promoters, and any change in their involvement could have a material adverse impact.
- ! The company has previously recorded negative cash flows and its borrowings have been rising, which may constrain its financial flexibility and growth plans.